- Home
- ZNTL vs RPID Comparison
ZNTL vs RPID Comparison
Compare ZNTL & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- RPID
- Stock Information
- Founded
- ZNTL 2014
- RPID 2006
- Country
- ZNTL United States
- RPID United States
- Employees
- ZNTL N/A
- RPID N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- RPID Medical Specialities
- Sector
- ZNTL Health Care
- RPID Health Care
- Exchange
- ZNTL Nasdaq
- RPID Nasdaq
- Market Cap
- ZNTL 105.8M
- RPID 106.5M
- IPO Year
- ZNTL 2020
- RPID 2021
- Fundamental
- Price
- ZNTL $1.42
- RPID $3.05
- Analyst Decision
- ZNTL Buy
- RPID Strong Buy
- Analyst Count
- ZNTL 6
- RPID 2
- Target Price
- ZNTL $6.53
- RPID $8.00
- AVG Volume (30 Days)
- ZNTL 729.8K
- RPID 70.7K
- Earning Date
- ZNTL 11-11-2025
- RPID 10-31-2025
- Dividend Yield
- ZNTL N/A
- RPID N/A
- EPS Growth
- ZNTL N/A
- RPID N/A
- EPS
- ZNTL N/A
- RPID N/A
- Revenue
- ZNTL $26,865,000.00
- RPID $30,289,000.00
- Revenue This Year
- ZNTL N/A
- RPID $16.63
- Revenue Next Year
- ZNTL N/A
- RPID $21.98
- P/E Ratio
- ZNTL N/A
- RPID N/A
- Revenue Growth
- ZNTL N/A
- RPID 22.57
- 52 Week Low
- ZNTL $1.01
- RPID $0.83
- 52 Week High
- ZNTL $4.46
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.87
- RPID 55.56
- Support Level
- ZNTL $1.40
- RPID $2.63
- Resistance Level
- ZNTL $2.02
- RPID $3.52
- Average True Range (ATR)
- ZNTL 0.11
- RPID 0.23
- MACD
- ZNTL -0.05
- RPID 0.09
- Stochastic Oscillator
- ZNTL 4.76
- RPID 62.04
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.